Evidence map›Paper›PMID 40236311›Full record

ArticleClinical case reports2025

Fulminant Type 1 Diabetes Mellitus With Concomitant Coxsackievirus B6 Antibody Elevation and RNA-Based COVID-19 Vaccination: A Case Report and Review of the Literature.

Hisaka Minami, Shinya Furukawa, Teruki Miyake, Keisho Kurokawa, Yasuhiro Sasaki, Masayuki Nakaishi, Kensuke Nagamatsu, Hiroka Yamago, Naozumi Shibata, Yoichi Hiasa and 1 more

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hisaka MinamiDepartment of Internal Medicine Ehime Prefectural Niihama Hospital Niihama Ehime Japan.
Shinya FurukawaHealth Services Center Ehime University Matsuyama Ehime Japan.ORCID https://orcid.org/0000-0002-0041-7688
Teruki MiyakeDepartment of Gastroenterology and Metabology Ehime University Graduate School of Medicine Toon Ehime Japan.
Keisho KurokawaDepartment of Cardiology, Pulmonary, Hypertension and Nephropathy Ehime University Graduate School of Medicine Toon Ehime Japan.
Yasuhiro SasakiDepartment of Cardiology Ehime Prefectural Niihama Hospital Niihama Ehime Japan.
Masayuki NakaishiDepartment of Urology Ehime Prefectural Niihama Hospital Niihama Ehime Japan.
Kensuke NagamatsuDepartment of Internal Medicine Yawatahama City General Hospital Yawatahama Ehime Japan.
Hiroka YamagoDepartment of Gastroenterology Ehime Prefectural Niihama Hospital Niihama Ehime Japan.
Naozumi ShibataDepartment of Gastroenterology Ehime Prefectural Niihama Hospital Niihama Ehime Japan.
Yoichi HiasaDepartment of Gastroenterology and Metabology Ehime University Graduate School of Medicine Toon Ehime Japan.ORCID https://orcid.org/0000-0003-4117-339X
Bunzo MatsuuraDepartment of Lifestyle-Related Medicine and Endocrinology Ehime University Graduate School of Medicine Toon Ehime Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fulminant type 1 diabetes is a rare but severe condition that can develop rapidly, often in association with viral infections. In this case, coxsackievirus B6 antibody levels were elevated after disease onset, though its significance remains unclear. This highlights the importance of thorough viral screening in fulminant type 1 diabetes and the need for further research to better understand potential contributing factors, including in post-vaccination contexts.

Indexed as

autoimmune diseaseCOVID‐19diabetestype 1 diabetesvaccine

Identifiers

PMID40236311
PMCPMC11997456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.